B ACUTE LYMPHOBLASTIC LEUKEMIA, BCR-ABL1-LIKE

Clinical trials for B ACUTE LYMPHOBLASTIC LEUKEMIA, BCR-ABL1-LIKE explained in plain language.

Never miss a new study

Get alerted when new B ACUTE LYMPHOBLASTIC LEUKEMIA, BCR-ABL1-LIKE trials appear

Sign up with your email to follow new studies for B ACUTE LYMPHOBLASTIC LEUKEMIA, BCR-ABL1-LIKE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Can a common nutrient shield young cancer patients from Chemo's toxic side effects?

Disease control Recruiting now

This study aims to see if adding a nutrient supplement called levocarnitine to standard chemotherapy can protect the liver in adolescents and young adults (ages 15-39) being treated for leukemia or lymphoma. A key chemotherapy drug, asparaginase, often causes severe liver damage …

Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA, BCR-ABL1-LIKE

Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

B ACUTE LYMPHOBLASTIC LEUKEMIA, BCR-ABL1-LIKE

Get alerted when new B ACUTE LYMPHOBLASTIC LEUKEMIA, BCR-ABL1-LIKE trials appear

Can a common nutrient shield young cancer patients from Chemo's toxic side effects?